BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18459114)

  • 1. Inhibition of histone acetyltransferase by glycosaminoglycans.
    Buczek-Thomas JA; Hsia E; Rich CB; Foster JA; Nugent MA
    J Cell Biochem; 2008 Sep; 105(1):108-20. PubMed ID: 18459114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
    Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
    Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate.
    Han J; Lachance C; Ricketts MD; McCullough CE; Gerace M; Black BE; Côté J; Marmorstein R
    J Biol Chem; 2018 Mar; 293(12):4498-4509. PubMed ID: 29382722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRG15 activates the cdc2 promoter via histone acetylation in human cells.
    Peña AN; Tominaga K; Pereira-Smith OM
    Exp Cell Res; 2011 Jul; 317(11):1534-40. PubMed ID: 21324423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disubstituted naphthyl β-D-xylopyranosides: Synthesis, GAG priming, and histone acetyltransferase (HAT) inhibition.
    Thorsheim K; Persson A; Siegbahn A; Tykesson E; Westergren-Thorsson G; Mani K; Ellervik U
    Glycoconj J; 2016 Apr; 33(2):245-57. PubMed ID: 27023911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel inhibitors of histone acetyltransferases.
    Eliseeva ED; Valkov V; Jung M; Jung MO
    Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the Molecular Roles of Histone Chaperones in Histone Acetylation by Type B Histone Acetyltransferases (HAT-B).
    Haigney A; Ricketts MD; Marmorstein R
    J Biol Chem; 2015 Dec; 290(51):30648-57. PubMed ID: 26522166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation.
    Hernández-Ledesma B; Hsieh CC; de Lumen BO
    Mol Nutr Food Res; 2011 Jul; 55(7):989-98. PubMed ID: 21618425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H3 specific acetyltransferases are essential for cell cycle progression.
    Howe L; Auston D; Grant P; John S; Cook RG; Workman JL; Pillus L
    Genes Dev; 2001 Dec; 15(23):3144-54. PubMed ID: 11731478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor.
    Trievel RC; Li FY; Marmorstein R
    Anal Biochem; 2000 Dec; 287(2):319-28. PubMed ID: 11112280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of histone acetyltransferase (HAT) in ethanol-induced acetylation of histone H3 in hepatocytes: potential mechanism for gene expression.
    Park PH; Lim RW; Shukla SD
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1124-36. PubMed ID: 16081763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assays for Validating Histone Acetyltransferase Inhibitors.
    Waddell AR; Liao D
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone acetyltransferases: challenges in targeting bi-substrate enzymes.
    Wapenaar H; Dekker FJ
    Clin Epigenetics; 2016; 8():59. PubMed ID: 27231488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
    Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
    Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A virus nucleoprotein is acetylated by histone acetyltransferases PCAF and GCN5.
    Hatakeyama D; Shoji M; Yamayoshi S; Yoh R; Ohmi N; Takenaka S; Saitoh A; Arakaki Y; Masuda A; Komatsu T; Nagano R; Nakano M; Noda T; Kawaoka Y; Kuzuhara T
    J Biol Chem; 2018 May; 293(19):7126-7138. PubMed ID: 29555684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone acetyltransferase activity of PCAF cooperates with the brahma/SWI2-related protein BRG-1 in the activation of the enhancer A of the MHC class I promoter.
    Brockmann D; Lehmkühler O; Schmücker U; Esche H
    Gene; 2001 Oct; 277(1-2):111-20. PubMed ID: 11602348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP.
    Nie S; Wu F; Wu J; Li X; Zhou C; Yao Y; Song Y
    Eur J Med Chem; 2022 Jul; 237():114407. PubMed ID: 35512565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal protein HMGN1 enhances the acetylation of lysine 14 in histone H3.
    Lim JH; West KL; Rubinstein Y; Bergel M; Postnikov YV; Bustin M
    EMBO J; 2005 Sep; 24(17):3038-48. PubMed ID: 16096646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase.
    Choudhury M; Shukla SD
    Alcohol Clin Exp Res; 2008 May; 32(5):829-39. PubMed ID: 18336638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rtt109-Vps75 histone acetyltransferase complex acetylates non-nucleosomal histone H3.
    Han J; Zhou H; Li Z; Xu RM; Zhang Z
    J Biol Chem; 2007 May; 282(19):14158-64. PubMed ID: 17369253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.